Reddy Swetha, Garcia Samuel, Hostetter Logan J, Finch Alexander S, Bellolio Fernanda, Guru Pramod, Gerberi Danielle J, Smischney Nathan J
Division of Critical Care, Mayo Clinic, Jacksonville, FL, USA.
Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, USA.
J Intensive Care Med. 2025 Feb;40(2):207-217. doi: 10.1177/08850666241303851. Epub 2024 Dec 5.
Extracorporeal cardiopulmonary resuscitation (ECPR) utilizes veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in cardiac arrest patients to reduce the risk of mortality and multiorgan dysfunction from systemic hypoperfusion. We aimed to compare clinical outcomes of patients receiving ECPR versus conventional cardiopulmonary resuscitation (CCPR) for refractory cardiac arrest.
This was a systematic review and meta-analysis. A librarian searched the main databases, Ovid MEDLINE (including epub ahead of print, in-process & other non-indexed citations), Ovid EMBASE and Ovid Cochrane Central Register of Controlled Trials from inception through July 2024.
We included randomized controlled trials and observational studies that compared the outcomes of ECPR to CCPR in cardiac arrest patients. Primary outcomes were neurological sequelae and survival.
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two reviewers independently screened articles, extracted data on selected articles and performed risk of bias assessments using ROBINS-I for non-randomized controlled trials and the revised Cochrane risk of bias tool for randomized controlled trials with disagreements settled by a third independent reviewer.
Out of 3458 studies identified and screened, 28 studies including 304,360 cardiac arrest patients met eligibility criteria and were included. Survival at hospital discharge was 20% for ECPR versus 3.3% for CCPR (OR 0.48 [CI 0.27, 0.84]). Favorable neurological outcome at hospital discharge was 11.8% for ECPR versus 1.9% for CCPR (OR 0.41 [CI 0.17, 1.01]). Complications from bleeding were ten times higher in the ECPR group (35.3% vs 3.7%; OR 0.08 [0.03, 0.24]).
ECPR appeared to be superior to CCPR for improved neurological outcome and survival in cardiac arrest patients, although bleeding was increased. There was large heterogeneity in the included studies and outcomes reported. Future prospective studies may improve the identification of subgroups of patients that will benefit most from ECPR.Systematic review and meta-analysis registration: PROSPERO - CRD42023394128.
体外心肺复苏(ECPR)利用静脉 - 动脉体外膜肺氧合(VA - ECMO)对心脏骤停患者进行救治,以降低因全身灌注不足导致的死亡风险和多器官功能障碍。我们旨在比较接受ECPR与传统心肺复苏(CCPR)治疗难治性心脏骤停患者的临床结局。
这是一项系统评价和荟萃分析。一名图书馆员检索了主要数据库,即从数据库建立至2024年7月的Ovid MEDLINE(包括印刷前的 epub、在研及其他未索引的引文)、Ovid EMBASE和Ovid Cochrane对照试验中央注册库。
我们纳入了比较心脏骤停患者ECPR与CCPR结局的随机对照试验和观察性研究。主要结局为神经后遗症和生存率。
我们遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南。两名评审员独立筛选文章,提取所选文章的数据,并使用ROBINS - I对非随机对照试验进行偏倚风险评估,对随机对照试验使用修订后的Cochrane偏倚风险工具,如有分歧则由第三位独立评审员解决。
在识别和筛选出的3458项研究中,28项研究(包括304,360名心脏骤停患者)符合纳入标准并被纳入。ECPR组出院时生存率为20%,而CCPR组为3.3%(比值比[OR] 0.48 [95%置信区间(CI)0.27, 0.84])。ECPR组出院时良好神经功能结局为11.8%,CCPR组为1.9%(OR 0.41 [CI 0.17, 1.01])。ECPR组出血并发症发生率高出10倍(35.3%对3.7%;OR 0.08 [0.03, 0.24])。
对于改善心脏骤停患者的神经功能结局和生存率,ECPR似乎优于CCPR,尽管出血风险增加。纳入研究和报告的结局存在较大异质性。未来的前瞻性研究可能会改善对最能从ECPR中获益的患者亚组的识别。系统评价和荟萃分析注册:PROSPERO - CRD42023394128